Marketing-authorisation holder · Germany
Cheplapharm Arzneimittel Gmbh
343 medicines in 7 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Germany
343 medicines in 7 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 343
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTOCORTINA 373 mg POLVO PARA SOLUCIÓN INYECTABLE500 mg · Polvo para solución inyectable | Hydrocortisone | Spain | Marketed | 1974 |
| ACTOCORTINA 75 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE100 mg · Polvo y disolvente para solución inyectable | Hydrocortisone | Spain | Marketed | 1958 |
| Actos | Pioglitazone | EU (EMA) | Authorised | 2000 |
| ACTOSCompressa | Pioglitazone | Italy | Authorised | |
| ACTOS 15 mg COMPRIMIDOS15 mg · Comprimido | Pioglitazone | Spain | Marketed | 2002 |
| ACTOS 15 mg COMPRIMIDOS15 mg · Comprimido | Pioglitazone | Spain | Marketed | 2001 |
| ACTOS 15 mg COMPRIMIDOS15 mg · Comprimido | Pioglitazone | Spain | Authorised | 2001 |
| ACTOS 15 mg COMPRIMIDOS15 mg · Comprimido | Pioglitazone | Spain | Authorised | 2001 |
| Actos 15 mg tablet, tablettenTablet | Pioglitazone | Netherlands | Authorised | 2000 |
| ACTOS 30 MG COMPRIMIDOS30 mg · Comprimido | Pioglitazone | Spain | Marketed | 2025 |
| ACTOS 30 MG COMPRIMIDOS30 mg · Comprimido | Pioglitazone | Spain | Marketed | 2025 |
| ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido | Pioglitazone | Spain | Authorised | 2001 |
| ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido | Pioglitazone | Spain | Marketed | 2001 |
| ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido | Pioglitazone | Spain | Marketed | 2002 |
| ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido | Pioglitazone | Spain | Authorised | 2001 |
| ACTOS 30 MG COMPRIMIDOS30 mg · Comprimido | Pioglitazone | Spain | Marketed | 2025 |
| Actos 30 mg tablet, tablettenTablet | Pioglitazone | Netherlands | Authorised | 2000 |
| Actos 45 mg tablet, tablettenTablet | Pioglitazone | Netherlands | Authorised | 2003 |
| ALDACTONECapsula rigida | Spironolactone | Italy | Authorised | |
| ANANDRON50 mg · Tablet | Nilutamide | Canada | Not marketed | 1997 |
| Anandron 150 mg, tablettenTablet | Nilutamide | Netherlands | Authorised | 1996 |
| ANEXATESoluzione iniettabile | Flumazenil | Italy | Authorised | |
| Anexate, 0,5 mg/5 ml en 1,0 mg/ 10 ml oplossing voor injectieOplossing voor injectie | Flumazenil | Netherlands | Authorised | 1988 |
| Anexate 0,5 mg/5 ml otopina za injekciju/infuzijuotopina za injekciju/infuziju | Flumazenil | Croatia | Marketed | 2016 |
| ANEXATE 0,5 mg/5 ml SOLUCION INYECTABLE0,1 mg · Solución inyectable | Flumazenil | Spain | Marketed | 1988 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 121 | 111 | 10 | CompaniesAll medicines |
| Netherlands | 88 | 88 | 0 | CompaniesAll medicines |
| Italy | 51 | 51 | 0 | CompaniesAll medicines |
| Canada | 47 | 43 | 4 | CompaniesAll medicines |
| Croatia | 24 | 24 | 0 | CompaniesAll medicines |
| European Union (EMA) | 8 | 8 | 0 | CompaniesAll medicines |
| Romania | 4 | 0 | 4 | CompaniesAll medicines |
Also in the registers of France, Serbia, United States
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.